<html><head></head><body><h1>Monjuvi</h1><p class="drug-subtitle"><b>Generic Name:</b> tafasitamab (TA fa SIT a mab)<br/>
<b>Brand Name:</b> <i>Monjuvi</i></p><ul class="ddc-anchor-links"><li>Uses</li>
<li>Warnings</li>
<li>Dosage</li>
<li>What to avoid</li>
<li>Side effects</li>
<li>Interactions</li></ul><h2 class="ddc-anchor-offset" id="uses">What is Monjuvi?</h2><p>Monjuvi (tafasitamab) is an antibody that targets the CD19 antigen.</p><p>Monjuvi is used in combination with lenalidomide to treat diffuse large B-cell lymphoma in adults who cannot receive a stem cell transplant.</p><p>Monjuvi is given after other cancer treatments did not work or have stopped working.</p><p>Monjuvi was approved by the US Food and Drug Administration (FDA) on an "accelerated" basis. In clinical studies, some people responded to this medicine, but further studies are needed.</p><h2 class="ddc-anchor-offset" id="warnings">Warnings</h2><p>Monjuvi affects your immune system. <b>You may get infections more easily, even serious or fatal infections.</b> Call your doctor if you have signs of infection (fever, cough with mucus, chest tightness, shortness of breath, or pain or burning when you urinate).</p><p><b>Monjuvi may harm an unborn baby.</b> Use effective birth control to prevent pregnancy while using Monjuvi and for at least 3 months after your last dose.</p><p>Carefully follow all instructions about the use of birth control while you are using Monjuvi in combination with lenalidomide.</p><h2>Before taking this medicine</h2><p>Tell your doctor if you have any signs of infection, or if you have recently had an infection.</p><p><b>Tafasitamab may harm an unborn baby.</b> Use effective birth control to prevent pregnancy while using this medicine and for at least 3 months after your last dose. Tell your doctor if you become pregnant.</p><p>Monjuvi is sometimes used in combination with lenalidomide. Both men and women using lenalidomide must use effective birth control. Even one dose can cause severe, life-threatening birth defects or death of a baby if the mother or the father is taking lenalidomide at the time of conception or during pregnancy.</p><p>Carefully follow all instructions about the use of birth control while you are using Monjuvi in combination with other medicines.</p><p><b>Do not breastfeed while receiving Monjuvi,</b> and for at least 3 months after your last dose.</p><h2>How is Monjuvi given?</h2><p>Monjuvi is given as an infusion into a vein. A healthcare provider will give you this injection.</p><p>Monjuvi is given in a 28-day treatment cycle. You may need to use the medicine only on certain days of each cycle. Your doctor will determine how long to treat you with this medicine.</p><p>This medicine must be given slowly, and the infusion can take up to 2.5 hours to complete.</p><p>You may be given other medications to help prevent serious side effects or an allergic reaction. Keep using these medicines for as long as your doctor has prescribed.</p><p>Monjuvi affects your immune system. You may get infections more easily, even serious or fatal infections. Your doctor will need to examine you on a regular basis.</p><h2 class="ddc-anchor-offset" id="dosage">Dosing information</h2><p><b>Usual Adult Dose of Monjuvi for Lymphoma:</b></p><p>12 mg/kg IV (based on actual body weight; Administer in combination with lenalidomide 25 mg orally for a maximum of 12 cycles, then continue this drug as monotherapy until disease progression or unacceptable toxicity:<br/>
CYCLE 1: 12 mg/kg IV on Days 1, 4, 8, 15, and 22<br/>
CYCLE 2: 12 mg/kg IV on Days 1, 8, 15, and 22<br/>
CYCLE 3: 12 mg/kg IV on Days 1 and 15<br/>
-NOTE: Each therapy cycle is 28 days.<br/>
-For the first infusion, use an infusion rate of 70 mL/h for the first 30 minutes, then increase the rate so that the infusion is administered within 1.5 to 2.5 hours; administer all subsequent infusions within 1.5 to 2 hours.<br/>
<br/>
Comments:<br/>
-Refer to the lenalidomide prescribing information for lenalidomide dosage recommendations.<br/>
-Administer premedications 30 minutes to 2 hours prior to starting infusion to minimize infusion-related reactions.<br/>
-Premedications may include acetaminophen, histamine H1 receptor antagonists, histamine H2 receptor antagonists, and/or glucocorticosteroids.<br/>
-For patients not experiencing infusion-related reactions during the first 3 infusions, premedication is optional for subsequent infusions.<br/>
-If a patient experiences an infusion-related reaction, administer premedications before each subsequent infusion.<br/>
<br/>
Use: This drug in combination with lenalidomide, is indicated for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) not otherwise specified, including DLBCL arising from low grade lymphoma, and who are not eligible for autologous stem cell transplant (ASCT)</p><h2>What happens if I miss a dose?</h2><p>Call your doctor for instructions if you miss an appointment for your Monjuvi injection.</p><h2>What happens if I overdose?</h2><p>Since this medicine is given by a healthcare professional in a medical setting, an overdose is unlikely to occur.</p><h2 class="ddc-anchor-offset" id="what-to-avoid">What should I avoid while receiving Monjuvi?</h2><p>Follow your doctor's instructions about any restrictions on food, beverages, or activity.</p><h2 class="ddc-anchor-offset" id="side-effects">Monjuvi side effects</h2><p>Get emergency medical help if you have <b>signs of an allergic reaction to Monjuvi:</b> hives; difficult breathing; swelling of your face, lips, tongue, or throat.</p><p>Some side effects may occur during the injection. Tell your caregiver if you feel chilled, warm, sweaty, anxious, or have a headache, trouble breathing, or pounding in your neck or ears.</p><p>Call your doctor at once if you have:</p><ul>
<li>
<p>cough with mucus, chest tightness, shortness of breath;</p>
</li>
<li>
<p>fever above 100.4 degrees F (38 degrees C);</p>
</li>
<li>
<p>pain or burning when you urinate;</p>
</li>
<li>
<p>easy bruising, unusual bleeding, purple or red spots under your skin;</p>
</li>
<li>
<p><b>low red blood cells (anemia)</b> - pale skin, unusual tiredness, feeling light-headed or short of breath, cold hands and feet; or</p>
</li>
<li>
<p><b>low white blood cell counts</b> - fever, mouth sores, skin sores, sore throat, cough, trouble breathing.</p>
</li>
</ul><p>cough with mucus, chest tightness, shortness of breath;</p><p>fever above 100.4 degrees F (38 degrees C);</p><p>pain or burning when you urinate;</p><p>easy bruising, unusual bleeding, purple or red spots under your skin;</p><p><b>low red blood cells (anemia)</b> - pale skin, unusual tiredness, feeling light-headed or short of breath, cold hands and feet; or</p><p><b>low white blood cell counts</b> - fever, mouth sores, skin sores, sore throat, cough, trouble breathing.</p><p>Your cancer treatments may be delayed or permanently discontinued if you have certain side effects.</p><p>Common Monjuvi side effects may include:</p><ul>
<li>
<p>low blood cell counts;</p>
</li>
<li>
<p>fever;</p>
</li>
<li>
<p>feeling weak or tired;</p>
</li>
<li>
<p>cough;</p>
</li>
<li>
<p>cold symptoms such as stuffy nose, sneezing, sore throat;</p>
</li>
<li>
<p>loss of appetite, diarrhea; or</p>
</li>
<li>
<p>swelling in your hands or lower legs.</p>
</li>
</ul><p>low blood cell counts;</p><p>fever;</p><p>feeling weak or tired;</p><p>cough;</p><p>cold symptoms such as stuffy nose, sneezing, sore throat;</p><p>loss of appetite, diarrhea; or</p><p>swelling in your hands or lower legs.</p><p>This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.</p><h2 class="ddc-anchor-offset" id="interactions">What other drugs will affect Monjuvi?</h2><p>Other drugs may interact with tafasitamab, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.</p><h2>More about Monjuvi (tafasitamab)</h2><ul class="more-resources-list more-resources-list-general">
<li>Side Effects</li>
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>Drug class: miscellaneous antineoplastics</li>
<li>FDA Approval History</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Advanced Reading</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Diffuse Large B-Cell Lymphoma</li>
</ul><h2>Further information</h2><p>Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use Monjuvi only for the indication prescribed.</p><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p><p class="ddc-copyright">Copyright 1996-2021 Cerner Multum, Inc. Version: 1.01.</p></body></html>